![]() |
|
|||||||||||||||||||||||||||||||||||||||||||
|
|
The Ontario Institute for Cancer Research Selects Geospiza for Next Generation Genetic Analysis SEATTLE, Washington – June 17, 2008 – Geospiza, Inc., the market leading developer of genetic analysis software, today announced that Geospiza will be providing its FinchLab™ software to the Ontario Institute for Cancer Research (OICR) to support their next generation research. In a highly competitive selection process, Geospiza’s FinchLab product was identified as the only out-of-the-box solution to meet OICR’s needs. OICR compared the Geospiza product against a wide range of alternatives, including custom development and internal development. FinchLab’s embedded best practices and speed to deploy will make it possible for the researchers at OICR and their partners to rapidly realize the benefit of their new instruments. OICR is a leading Cancer Research facility staffed by some of the world’s most accomplished researchers. “We are thrilled to have the opportunity to work with OICR in support of their important research”, said Todd Smith, CEO of Geospiza. “We look forward to collaborating with OICR as we continue to work with the community to translate new technologies into packaged solutions.” Geospiza’s FinchLab provides a common platform in support of multiple genetic analysis technologies, including the Next Generation sequencing instruments (Illumina Genome Analyzer and Applied Biosystems SOLiD) operated by OICR. With development efforts driven by biologists, Geospiza has established substantial collaborative partnerships with leading researchers, instrument manufacturers and industry visionaries to support new and emerging science. About OICR About Geospiza For more information, contact: |
|
|
||||||||||||||||||||||||||||||||||||||||
©Copyright 1997-2008 Geospiza, Inc. All rights reserved. |
||||||||||||||||||||||||||||||||||||||||||||